ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Pigmanorm, Crème - 30 g
46769015 Louis Widmer AG
Pigmanorm, Crème07.11.1985
  07.11.1985
Hydroquinone (D11AX11) 
WHO-DDD 
10.99.30 g
10.99. 
B  
Yes 
IPCI
9.51No
    
10 %26.75
  
7680467690155Synthetika
1197080 
Composition
hydrochinonum 50 mg, tretinoinum 0.3 mg, dexamethasonum 0.3 mg, propylenglycolum 70.4 mg, glyceroli monostearas 40-55, natrii cetylo- et stearylosulfas, paraffinum liquidum, isopropylis myristas, vaselinum album, octinoxatum, avobenzonum, alcohol cetylicus 15 mg, dexpanthenolum, ethanolum, dextrocamphora, E 171, sorbitolum liquidum non cristallisabile, int-rac-alpha-tocopherylis acetas, acidum citricum monohydricum, acidum ascorbicum, E 218 1.5 mg, propylis parahydroxybenzoas 500 µg, acidum lacticum, dinatrii edetas, E 320 40 µg, E 321 40 µg, aqua purificata, ad unguentum pro 1 g.
Packungsbestandteile
Cream 
 
Active AgentDose
Dexamethasone0.3 mg
Hydrochinone50 mg
Tretinoin0.3 mg
BAG: Active AgentDose
Dexamethasone0.3 mg
Hydrochinone50 mg
Tretinoin0.3 mg
 
Inactive agentsDoseadditional_information
Ascorbic Acid  
Citric Acid Monohydrate  
Lactic Acid  
Ad Unguentum1 g 
Alcohol Cetylicus15 mg 
Aqua Purificata  
Avobenzone  
Dexpanthenol  
Dextrocamphor  
Dinatrii Edetas  
E 171 color.
E 2181.5 mgconserv.
E 32040 µgconserv.
E 32140 µgconserv.
Ethanol  
Glyceroli Monostearas40-55 
Int-Rac-Alpha-Tocopherylis Acetas  
Isopropyl Myristate  
Natrii Cetylo-  
Octinoxatum  
Paraffine Liquide  
Propylenglycol70.4 mg 
Propylis Parahydroxybenzoas500 µg 
Sorbitolum Liquidum non Cristallisabile  
Stearylosulfas  
Vaselinum Album  
 
Source
Data was imported : 17.11.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | Login | Contact | Home